Brief: Cross Country Healthcare Q4 Adjusted EPS USD 0.29 Vs. IBES Estimate USD 0.27
21/02/2024 21:15
Feb 21 (Reuters) - Cross Country Healthcare Q4 gross margin 21.9%. * Q4 net income USD 9.038 million * Q4 revenue USD 414.035 million vs. IBES estimate USD 404.4 million * Q4 adjusted EBITDA USD 20.592 million * Q4 EPS USD 0.26 * Q4 adjusted EBITDA margin 5%
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million